Health Care & Life Sciences » Biotechnology | Viking Therapeutics Inc.

Viking Therapeutics Inc.

Viking Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.38
Market Cap
$591.51 M
Shares Outstanding
72.05 M
Public Float
63.4 M

Profile

Address
12340 El Camino Real
San Diego California 92130
United States
Employees -
Website http://www.vikingtherapeutics.com
Updated 07/08/2019
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. Its clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in development of VK2809 and VK0214.

Financials

View All

Brian Lian
President, Chief Executive Officer & Director
Matthew W. Foehr
Director